This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Contributors
  • Rita McLauchlan

Rita McLauchlan


Vitreoretinal Nurse Practitioner


Manchester Royal Eye Hospital, Central Manchester University Hospital Foundation Trust, Manchester, UK.

Latest Contribution


Image of an eye

A short survey of the views of clinicians on the role of procedure-specific consent forms

1 October 2018 | Hamza Zafar, SZ Tan, SJ Charles, Niall Patton, A Jalil, G Turner, Rita McLauchlan, D Park, FD Scala | EYE - General

Informed consent is an ethical and legal right of every patient [1]. It is essential that patients receive clear, concise and accurate information regarding the risks, benefits and alternatives to a potential intervention. In addition to this, the patient must...


Introduction of the Mydriasert insert at the Manchester Royal Eye Hospital

1 August 2018 | Rita McLauchlan, Julie Williams, Arun Brahma | EYE - Cornea, EYE - General

The authors report on a study to examine the effects of the Mydriasert insert on time, effects, patient comfort and tolerability at Manchester Royal Eye Hospital. Mydriasert is an insoluble ophthalmic insert indicated for mydriasis prior to ophthalmic surgery, which...


Intravitreal injections delivered by ophthalmic clinical nurse specialists

1 June 2015 | Rita McLauchlan, D Armstrong, Konstantinos Balaskas, Sajjad Mahmood | EYE - Vitreo-Retinal

Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...


People
A-Z Filter
ABCDEFGHIJKLMNOPQRSTUVWXYZ
View all people

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency